Viewing Study NCT04856761


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2026-01-30 @ 11:01 PM
Study NCT ID: NCT04856761
Status: UNKNOWN
Last Update Posted: 2022-08-18
First Post: 2021-04-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Neoplasms View
None Recurrence View
None Cholangiocarcinoma View
None Gall Bladder Cancer View
Keywords: